SCHEMBL4099175

SCHEMBL4099175

CCOc1ccc2c(c1)c(C(=O)C(=O)Nc1ncccn1)c(C(F)(F)F)n2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
F2RL3 Q96RI0 1/20 0.37
FAAH O00519 1/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
EPHX2 P34913 1/20 0.36
MAPT P10636 1/20 0.36
TP53 P04637 1/20 0.35
PLA2G2A P14555 1/20 0.35
SLC2A1 P11166 1/20 0.35
PPARG P37231 1/20 0.34
USP2 O75604 1/20 0.34
EDNRB P24530 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4386508 0.97 PLA2G2A (0.40) ALOX5APLMNASMN1; SMN2F2RL3FAAH
SCHEMBL4095857 0.93 PLA2G2A (0.42) ALOX5APF2RL3FAAHEPHX2MAPT
SCHEMBL3007424 0.92 NPC1 (0.38) ALOX5APLMNASMN1; SMN2F2RL3FAAH
SCHEMBL4088892 0.91 EPHX2 (0.40) LMNASMN1; SMN2FAAHMEN1KMT2A
SCHEMBL4088383 0.90 FAAH (0.46) ALOX5APFAAH
SCHEMBL3005046 0.90 FAAH (0.41) ALOX5APLMNASMN1; SMN2F2RL3FAAH
SCHEMBL3008903 0.90 MEN1 (0.41) ALOX5APLMNASMN1; SMN2F2RL3MEN1
SCHEMBL3010861 0.90 MEN1 (0.44) LMNASMN1; SMN2FAAHMEN1POLB
SCHEMBL3001645 0.89 LMNA (0.40) ALOX5APLMNASMN1; SMN2FAAHMEN1
SCHEMBL4089977 0.89 TP53 (0.43) LMNASMN1; SMN2F2RL3FAAHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 ALOX5AP 26/4885LMNA 4089/4885SMN1; SMN2 4055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.